Financial statement analysis

Post-Pandemic Retail Investments to Focus on Boosting Store Profitability

Retrieved on: 
星期一, 九月 13, 2021
Retail, CFA, State Development & Investment Corporation, CEO, Efficiency, Overalls, Research report, Solution, ASA, Millennials, Financial statement analysis, Name, GLOBE, Compliance, SEC, Research, DM, Online shopping

The study points towards a renewed focus by retail management teams on store efficiencies as consumers, including millennials, return to in-person shopping.

Key Points: 
  • The study points towards a renewed focus by retail management teams on store efficiencies as consumers, including millennials, return to in-person shopping.
  • The study found that:
    Ninety percent of transactions for public retailers are completed in-store, not online (even during a pandemic).
  • A Physical Retail Composite Index shows the same-store sales trended solidly positive in the past three years with stable profitability.
  • "As a result, it's critical for retailers to step up store investment to ensure brand relevance and customer connectivity.

Healthcare Analytics Market to Reach $96.90 Bn, Globally, by 2030 at 15.3% CAGR: Allied Market Research

Retrieved on: 
星期一, 九月 6, 2021
Articles, Business intelligence, Data management, Formal sciences, Data analysis, Health care, Prescriptive analytics, Analytics, Predictive analytics, Electronic health record, Big data, Draft:Big data analytics

According to the report published by Allied Market Research, the global healthcare analytics market was estimated at $23.51 billion in 2020 and is expected to hit $96.90 billion by 2030, registering a CAGR of 15.3% from 2021 to 2030.

Key Points: 
  • According to the report published by Allied Market Research, the global healthcare analytics market was estimated at $23.51 billion in 2020 and is expected to hit $96.90 billion by 2030, registering a CAGR of 15.3% from 2021 to 2030.
  • This, in turn, has driven the global healthcare analytics market.
  • Based on application, the financial analysis segment contributed to the largest share in 2020, holding more than two-fifths of the global healthcare analytics market.
  • Growing government healthcare regulations to reduce the rising healthcare costs and increasing regulatory requirements propel the need for healthcare analytics in the region.

Healthcare Analytics Market to Reach $96.90 Bn, Globally, by 2030 at 15.3% CAGR: Allied Market Research

Retrieved on: 
星期一, 九月 6, 2021
Articles, Business intelligence, Computing, Formal sciences, Data analysis, Analytics, Big data, Prescriptive analytics, Electronic health record, Predictive analytics, Health data, Draft:Big data analytics

PORTLAND, Ore., Sept. 6, 2021 /PRNewswire/ -- Allied Market Research published a report, titled, "Healthcare Analytics Market by Application (Financial Analysis, Operational & Administrative Analysis and Clinical Analysis), Component (Hardware, Software and Services), Deployment Model (On-Premise and On-Demand), End User (Healthcare Payers, Healthcare Providers and Others), and Type (Descriptive Analytics, Predictive Analytics, and Prescriptive Analytics): Global Opportunity Analysis and Industry Forecast, 2021–2030." According to the report published by Allied Market Research, the global healthcare analytics market was estimated at $23.51 billion in 2020 and is expected to hit $96.90 billion by 2030, registering a CAGR of 15.3% from 2021 to 2030.

Key Points: 
  • PORTLAND, Ore., Sept. 6, 2021 /PRNewswire/ -- Allied Market Research published a report, titled, "Healthcare Analytics Market by Application (Financial Analysis, Operational & Administrative Analysis and Clinical Analysis), Component (Hardware, Software and Services), Deployment Model (On-Premise and On-Demand), End User (Healthcare Payers, Healthcare Providers and Others), and Type (Descriptive Analytics, Predictive Analytics, and Prescriptive Analytics): Global Opportunity Analysis and Industry Forecast, 20212030."
  • According to the report published by Allied Market Research, the global healthcare analytics market was estimated at $23.51 billion in 2020 and is expected to hit $96.90 billion by 2030, registering a CAGR of 15.3% from 2021 to 2030.
  • Based on application, the financial analysis segment contributed to the largest share in 2020, holding more than two-fifths of the global healthcare analytics market.
  • Growing government healthcare regulations to reduce the rising healthcare costs and increasing regulatory requirements propel the need for healthcare analytics in the region.

Golden Star Enterprises Ltd. Welcomes Second Advisory Board Member Raz Yaron

Retrieved on: 
星期三, 八月 11, 2021
Cloud, Implementation, Intention, Business development, The Advisory Board Company, CEO, Golden Star, Company, Forecasting, Operation, Technology, Telecommunication, Entrepreneurship, Insurance, Financial statement analysis, OTC Markets Group, Acquisition, Advisory board, GLOBE, Managed services, Consultant, Software development, Management, Risk management

Claymont, Delaware, Aug. 11, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Golden Star Enterprises, Ltd. (OTC Pink: GSPT) announces the appointment of Mr. Raz Yaron as the second member of our recently established Advisory Board.

Key Points: 
  • Claymont, Delaware, Aug. 11, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Golden Star Enterprises, Ltd. (OTC Pink: GSPT) announces the appointment of Mr. Raz Yaron as the second member of our recently established Advisory Board.
  • Mr. Kling, CEO of Golden Star, commented, Our goal in establishing the Advisory Board was to bring unique expertise and focus to the company to complement experienced board members and our existing management.
  • Raz is a great asset to Golden Star, and I am very happy he has joined our Advisory Board.
  • About Golden Star Enterprises Ltd.
    Golden Star Enterprises Ltd. (GSPT) is a publicly-traded holding and acquisition company interested in taking technology start-ups and growing them to the next level.

AC Immune Reports Second Quarter 2021 Financial Results and Provides Corporate Update

Retrieved on: 
星期三, 八月 4, 2021
Medical specialties, Branches of biology, Clinical medicine, Vaccination, Alpha-synuclein, Lewy body dementia, Vaccine, Parkinson's disease

LAUSANNE, Switzerland, Aug. 04, 2021 (GLOBE NEWSWIRE) -- AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today reported its financial results for the quarter ended June 30, 2021, and provided a corporate update.

Key Points: 
  • Announced an all-stock acquisition of Affiris portfolio of therapeutics targeting alpha-synuclein notably PD01, a clinically validated active vaccine candidate that places AC Immune at the forefront of Parkinsons disease drug development.
  • The study is currently under analysis and AC Immune plans to present the results at an international Alzheimer conference.
  • SupraAntigen is a registered trademark of AC Immune SA in the following territories: AU, EU, CH, GB, JP and RU.
  • Morphomer is a registered trademark of AC Immune SA in CN, CH, GB, JP, and NO.

ASA Gold and Precious Metals Limited Reports Financial Results for the Six Months Ended May 31, 2020

Retrieved on: 
星期五, 七月 10, 2020
Mining, Minerals, Natural Resources, Economy, Finance, Money, Foreign exchange market, Fundamental analysis, Stock market, Registered Investment Adviser, Financial statement analysis, Investment decisions, Investment

The Company employs bottom-up fundamental analysis and relies on detailed primary research including meetings with company executives, site visits to key operating assets, and proprietary financial analysis in making its investment decisions.

Key Points: 
  • The Company employs bottom-up fundamental analysis and relies on detailed primary research including meetings with company executives, site visits to key operating assets, and proprietary financial analysis in making its investment decisions.
  • Investors are encouraged to visit the Companys website for additional information, including historical and current share prices, news releases, financial statements, tax and supplemental information.
  • The site may be found at www.asaltd.com , or you may contact the Company directly at (800) 432-3378.
  • Investment advisory services for the Company are provided by Merk Investments LLC (Merk), an SEC registered investment adviser.

KAMSouth’s Christian Koch Wins Outstanding Paper Award at the American Society For Competitiveness Conference

Retrieved on: 
星期五, 十一月 1, 2019
Consulting, Accounting, Professional services, Finance, Economy, Finance, Money, Investment, Valuation, Security Analysis, Financial statement analysis, Value investing

Financial advisor Christian G. Koch of KAMSouth was a speaker at the American Society For Competitiveness Conference held on October 24-26, 2019 in Washington, DC.

Key Points: 
  • Financial advisor Christian G. Koch of KAMSouth was a speaker at the American Society For Competitiveness Conference held on October 24-26, 2019 in Washington, DC.
  • View the full release here: https://www.businesswire.com/news/home/20191101005031/en/
    Christian Koch West Wing (Photo: Business Wire)
    The Corporate Brand: Empirical Findings was a featured paper presentation at the 2019 American Society of Competitiveness conference.
  • Mr. Koch continues, "We have developed a design science model for financial analysis, investment decision making and security analysis.
  • The new model is grounded in the value investing literature from the 1930s and the textbook Security Analysis by Graham and Dodd."

ASA Gold and Precious Metals Limited Reports Financial Results for the Nine Months Ended August 31, 2019

Retrieved on: 
星期四, 九月 19, 2019
Finance, Natural Resources, Professional services, Mining, Minerals, Economy, Finance, Money, Foreign exchange market, Fundamental analysis, Stock market, Registered Investment Adviser, Financial statement analysis, Investment decisions, Investment

The Company employs bottom-up fundamental analysis and relies on detailed primary research including meetings with company executives, site visits to key operating assets, and proprietary financial analysis in making its investment decisions.

Key Points: 
  • The Company employs bottom-up fundamental analysis and relies on detailed primary research including meetings with company executives, site visits to key operating assets, and proprietary financial analysis in making its investment decisions.
  • Investors are encouraged to visit the Companys website for additional information, including historical and current share prices, news releases, financial statements, tax and supplemental information.
  • The site may be found at www.asaltd.com, or you may contact the Company directly at (800) 432-3378.
  • Investment advisory services for the Company are provided by Merk Investments LLC (Merk), an SEC registered investment adviser.